ALLMedicine™ Candidiasis Center
Research & Reviews 1,606 results
Nature Reviews. Urology; Masone MC
Sep 23rd, 2021 - Ibrexafungerp to treat acute vulvovaginal candidiasis.|2021|Masone MC,|
The Medical Letter on Drugs and Therapeutics;
Sep 23rd, 2021 - Ibrexafungerp (Brexafemme) for vulvovaginal candidiasis.|2021||
European Journal of Pharmaceutical Sciences : Official Jo... Zimmermann ES, Ferreira LM et. al.
Sep 20th, 2021 - The aim of this study was to evaluate the in vitro antifungal action of a diphenyl diselenide-loaded poly(ε-caprolactone) nanocapsules suspension (NC-1) and incorporate it into a gellan gum hydrogel formulation in order to assess its in vivo effic...
The Journal of Investigative Dermatology; Peterson P, Kisand K et. al.
Sep 19th, 2021 - The core function of the immune response is to distinguish between self and foreign. The multiorgan human autoimmune disease, autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED/autoimmune polyendocrine syndrome type 1) is an ex...
Drug Delivery; Abd-Elsalam WH, Nagy YI et. al.
Sep 15th, 2021 - Vulvovaginal candidiasis is a pervasive gynecological condition among women worldwide due to infection recurrence and resistance to conventional drugs. This calls for a novel formulation of alternative medication and with enhanced efficacy. This s...
Guidelines 8 results
HIV Medicine 7 References; Dockrell DH, O’Shea D et. al.
Nov 2nd, 2019 - British HIV Association/British Infection Association guidelines on the management of opportunistic infection in people living with HIV: The clinical management of Candidiasis 2019.|2019|Dockrell DH,O’Shea D,Cartledge JD,Freedman AR,|diagnosis,dru...
American Journal of Respiratory and Critical Care Medicine; Hage CA, Carmona EM et. al.
Aug 31st, 2019 - Background: Fungal infections are of increasing incidence and importance in immunocompromised and immunocompetent patients. Timely diagnosis relies on appropriate use of laboratory testing in susceptible patients.Methods: The relevant literature r...
Haematologica Tissot F, Agrawal S et. al.
Dec 25th, 2016 - The European Conference on Infections in Leukemia (ECIL) provides recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy strategies for various types of infection in patients with hematologic malignancies or he...
Journal of the American Dental Association (1939); Plemons JM, Al-Hashimi I et. al.
Aug 2nd, 2014 - Xerostomia, also known as "dry mouth," is a common but frequently overlooked condition that is typically associated with salivary gland hypofunction, which is the objective measurement of reduced salivary flow. Patients with dry mouth exhibit symp...
Intensive Care Medicine; Montravers P, Dupont H et. al.
Oct 25th, 2013 - Intra-abdominal candidiasis: the guidelines-forgotten non-candidemic invasive candidiasis.|2013|Montravers P,Dupont H,Eggimann P,|therapeutic use,drug effects,drug therapy,microbiology,drug therapy,microbiology,
Drugs 380 results see all →
News 156 results
Jun 2nd, 2021 - The US Food and Drug Administration (FDA) has approved ibrexafungerp tablets (Brexafemme) as a 1-day oral therapy for vaginal yeast infections, something 3 out of every 4 women encounter at least once in their life. Ibrexafungerp is the first drug...
Apr 24th, 2021 - Secukinumab is the latest adult plaque psoriasis treatment to be bested by a newcomer, the interleukin 17A and 17F blocker bimekizumab. Rates of complete clearance were substantially higher with bimekizumab in a phase 3 trial with 743 patients wit...
Feb 12th, 2021 - This transcript has been edited for clarity. Matthew F. Watto, MD: Welcome back to The Curbsiders. I'm Dr Matthew Watto, and I'm joined by my two good friends and board-certified internal medicine physicians, Dr Stuart Brigham and Dr Paul Williams...
Jan 30th, 2020 - Polyuria, polydipsia, and polyphagia are clinical signs and symptoms of type 2 DM. Other symptoms of type 2 DM include blurred vision, lower extremity paresthesia, and repeated candidiasis (candida balanitis in male patients). Chest pain and short...
Jan 9th, 2020 - The US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for use of micafungin sodium (Mycamine, Astellas Pharma Inc) for injection in children younger than 4 months of age. The indication spans candidemia,...